Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. |
United States | 1 Dec 2014 | Acquisition USD 3,500,000,000 (USD 3,500,000,000) deal size. Initial investment. Led the investment round. Active |